Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9

Cisplatin-based chemotherapy is the most commonly used treatment regimen for gastric cancer (GC), however, the resistance to cisplatin represents the key limitation for the therapeutic efficacy. Aberrant expression of MiR-524-5p appears to be involves in tumorigenesis and chemoresistance. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jing, Xue, Xiaofeng, Hong, Han, Qin, Mingde, Zhou, Jin, Sun, Qing, Liang, Hansi, Gao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352179/
https://www.ncbi.nlm.nih.gov/pubmed/27880941
http://dx.doi.org/10.18632/oncotarget.13479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352179/
https://www.ncbi.nlm.nih.gov/pubmed/27880941
http://dx.doi.org/10.18632/oncotarget.13479

Ejemplares similares